Table 3.
Characteristics of patients | Control | Trial | P |
Sex | |||
Male (%) | 104 (54) | 169 (53) | 0.934 |
Female (%) | 88 (46) | 147 (47) | 0.927 |
Age-yr median(IQR 25th & 5th) | 35 (23.75-45) | 35 (27-45) | 0.229 |
Weight (kg, mean ± SD) | 37.61 ± 5.94 | 38.32 ± 6.08 | 0.199 |
Ethnicity (%)1 | |||
Tribals | 171(89) | 287(91) | 0.883 |
Others | 21(11) | 29(9) | 0.559 |
Habits (%) | |||
Smoking | 58 (30.2) | 103 (32.6) | 0.685 |
Alcohol | 23 (12) | 33 (10.4) | 0.633 |
Both | 26 (13.5) | 53 (16.7) | 0.403 |
Socio-Economic status (%) | |||
Upper-Middle | 20 (10.4) | 40 (12.6) | 0.499 |
Middle | 30 (15.6) | 52 (16.4) | 0.833 |
Lower | 142 (74) | 224 (71) | 0.763 |
Pulmonary (%)2 | |||
Open cases (sputum +ve) | 67 (35) | 137 (43.4) | 0.214 |
Parenchymal | 152 (79.2) | 258 (81.6) | 0.822 |
Cavitary | 18 (9.4) | 66 (21) | 0.003 |
Effusion | 9 (4.6) | 20 (6.3) | 0.464 |
Fibrosis | 27 (14) | 68 (21.5) | 0.081 |
Extra pulmonary (%)2 | |||
Cervical lymph node | 18 (9.4) | 31 (9.8) | 0.883 |
Abdominal | 4 (2.1) | 6 (2) | 0.886 |
Laryngeal | 7 (3.6) | 11 (3.5) | 0.925 |
Central nervous system | 6 (3.1) | 6 (2) | 0.389 |
Bones/Joints | 10 (5.2) | 19 (6) | 0.72 |
Skin | 0 | 3 (1) | 0.598 |
Genito-Urinary | 2 (1.04) | 1 (0.3) | 0.304 |
Type of case (%) | |||
New | 140 (73) | 195 (61.7) | 0.245 |
Relapse | 43 (22.4) | 97 (30.7) | 0.122 |
Chronic | 9 (4.7) | 24 (7.6) | 0.225 |
Hematology | |||
Hb (%) | 8.84 ± 1.93 | 8.95 ± 1.95 | 0.808 |
Total leucocyte count/mm3 | 10 179 ± 4 680 | 9575 ± 4075 | 0.478 |
ESR | 66.79 ± 30.64 | 70.49 ± 27.91 | 0.517 |
Liver Function (mean, 95%CI) | |||
Serum bilirubin | 1.07 (0.7-1.3) | 1.09 (0.8-1.4) | 0.952 |
AST | 34.35 (17-63) | 32.4 (11-61) | 0.658 |
ALT | 27.45 (9-57) | 31.15 (6-52) | 0.655 |
ALP | 100 (50-260) | 107 (50-260) | 0.092 |
Unless stated otherwise, P values were calculated with the use of a two sided t-test with Welch’s modification (when unequal variance) for continuous data and a χ2 test for categorical data.
Ethnic group was assessed by investigation on screening. Tribal consists of Chaudhari, Gamit, Vasava, Bhil, Valvi, Nayka and Halpati.
Patients may belong to more than one category. ALP: Alkaline phosphatase.